JDVNX
Price
$23.59
Change
+$0.14 (+0.60%)
Updated
Jun 12 closing price
Net Assets
17.49B
RMFEX
Price
$58.31
Change
+$0.33 (+0.57%)
Updated
Jun 12 closing price
Net Assets
105.64B
Interact to see
Advertisement

JDVNX vs RMFEX

Header iconJDVNX vs RMFEX Comparison
Open Charts JDVNX vs RMFEXBanner chart's image
JHancock Disciplined Value NAV
Price$23.59
Change+$0.14 (+0.60%)
VolumeN/A
Net Assets17.49B
American Funds American Mutual R4
Price$58.31
Change+$0.33 (+0.57%)
VolumeN/A
Net Assets105.64B
JDVNX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVNX vs. RMFEX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVNX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 106B vs. JDVNX (17.5B). RMFEX pays higher dividends than JDVNX: RMFEX (1.58) vs JDVNX (1.08). JDVNX was incepted earlier than RMFEX: JDVNX (16 years) vs RMFEX (23 years). RMFEX (0.62) and JDVNX (0.61) have similar cost to investors . JDVNX is a more actively managed with annual turnover of: 48.00 vs. RMFEX (31.00). JDVNX has a lower initial minimum investment than RMFEX: JDVNX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 9.82 vs. JDVNX (-2.78). RMFEX return over 5 years is better than : 63.58 vs. JDVNX (46.94).
JDVNXRMFEXJDVNX / RMFEX
Total Expense Ratio0.600.6297%
Annual Report Gross Expense Ratio0.610.6298%
Fund Existence16 years23 years-
Gain YTD4.0836.97859%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets17.5B106B17%
Annual Yield % from dividends1.081.5869%
Returns for 1 year-2.789.82-28%
Returns for 3 years13.9129.4347%
Returns for 5 years46.9463.5874%
Returns for 10 years38.5778.4149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
URGN11.083.78
+51.78%
UroGen Pharma Ltd
TCRX1.610.01
+0.62%
TScan Therapeutics
MIDD143.88-2.83
-1.93%
Middleby Corp
RUM8.80-0.21
-2.33%
Rumble
NHPBP13.58-0.33
-2.37%
National Healthcare Properties Inc